Journal of the European Academy of Dermatology and Venereology

Article	Citations
Announcement	386
Editor's Picks January 2024	251
Announcement	146
	132
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	128
Announcement	124
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	119
Paradoxical joint and muscle pain in a patient treated with anifrolumab and belimumab	112
Louis Adolphus Duhring: An enduring legacy	110
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	99
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	89
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	84
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	80
Are non‐fungible tokens the barrier to realizing the Dermoverse?	80
Impact of menopause on the skin…information still insufficient	77
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	77
	77
Issue Information	76
	71
Announcement	70
Announcement	68
Contact allergy may enhance further sensitization to new chemicals, but individual susceptibility traits are important for polysensitization	68
The affliction of job, as painted by Jusepe de Ribera: A dermatological observation going back to the 17th century	67
Comment on ‘Efficacy and tolerance of dupilumab in patients with moderate‐to‐severe atopic dermatitis and obesity’ by Dupuis et al.	66
A case of eruptive halo nevi following COVID‐19	64

Juvenile localized scleroderma: A single‐centre experience from India	64
Dalbavancin for the treatment of severe hidradenitis suppurativa	64
The chicken or the egg of lymphopenia in atopic eczema	63
The future of digital pills and their potential use in dermatological clinical trials	62
Pharmacovigilance: The responsibility of all	61
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	60
Educational, labour market and relationship outcomes in people with acne	57
Rituximab in immunobullous disorders during the COVID‐19 pandemic: A systematic review of observational studies	56
Editor’s Picks June 2025	55
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	55
Identification of children at risk for the development of severe paediatric plaque psoriasis: Findings from the prospective observational long‐term Child‐CAPTURE registry	53
Peer review, scientific publishing and the law of reciprocity	50
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	46
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	46
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	46
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	44
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	44
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma	44
Paediatric psoriasis and biologics: An evidence gap in plain sight	44
Hidradenitis suppurativa: One step forward in timely diagnosis and appropriate treatment	44
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	44
Translating 6‐year trial safety data of upadacitinib in atopic dermatitis into clinical practice	43
The need for African dermatology guidelines—Steps towards equitable care	43
NPWT in skin transplantation: Promising, but is the jury still out?	42
Microinfusion of 5‐fluorouracil using a tattooing machine in keloid treatment	42
A new era for alopecia areata: New treatments and improved knowledge of the condition	42
Can we trust AI for acne advice: A double‐blind performance comparison with NICE guidelines	42
Two cases of cerebrovascular accidents following the induction dose of risankizumab	40
New onset of systemic lupus erythematosus following COVID‐19 mRNA vaccination	40
Editor’s Picks February 2026	40
Drug survival of alitretinoin treatment for chronic hand eczema: A Danish nationwide cohort study	39
Clinical and molecular diagnosis of genodermatoses: Review and perspectives	39
Editor’s Picks December 2025	39
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	39
Global study reveals almost half of patients with skin disease suffer from sleep disturbances and identifies predictive factors	38
Complete FLG genotyping is essential in stratification of FLG ‐associated disease	37
Real‐life efficacy and safety of upadacitinib in adolescents with moderate‐to‐severe atopic dermatitis unresponsive to dupilumab: A case series	37
Genomic and proteomic insights into hidradenitis suppurativa	37
Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 2 study	36
Disproportionate quality of life decline and unaddressed limitations in amlitelimab atopic dermatitis trial	36
Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations	36
Associations of skin cancer, dermatitis and risk factors for skin conditions with epigenetic aging	36
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	36
Genetic susceptibility in early‐onset melanoma: An observational Greek cohort study	35
Shedding pounds, easing plaques: Weight management in psoriasis	35
Barrier function‐related genes and proteins have an altered expression in acne‐involved skin	35
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study	35
Career intentions and practice expectations among French residents and early‐career dermatologists	35
Systemic effects of sunlight: 10‐year review of cardiovascular, infection and cancer outcomes	35
Deep learning predicted perceived age is a reliable approach for analysis of facial ageing: A proof of principle study	35

Reply to comments by Tadulewicz and Muklewicz on socio‐economic outcomes of atopic dermatitis	34
Global burden of major depressive disorder attributable to psoriasis, 2000–2021	34
Risk analysis of systemic side effects of tumescent local anaesthesia in the surgical treatment of geriatric and multimorbid patients with skin cancer	34
Interpreting severity in atopic dermatitis: Refining severity bands using clinical trial data	34
Biomarkers in rosacea: A systematic review	33
Medical history questionnaire in suspected intolerance to metal and non‐metal implants	33
Systemic neurokinin‐1 receptor antagonists mitigate chronic pruritus: A systematic review and meta‐analysis	33
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	33
Melanoma in women of childbearing age and in pregnancy in California, 1994–2015: a population‐based cohort study	33
Efficacy of imiquimod in the management of lentigo maligna	33
Advances in biologic therapy of psoriasis	33
Response to ‘Cardiovascular and thromboembolic risks of JAK inhibitors in atopic dermatitis: A global cohort study’	33
Detecting T‐cell receptor clonality in patients with severe atopic dermatitis refractory to dupilumab	33
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review	32
Chat GPT in dermatology: Progressive or problematic?	32
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study	32
Predictors of clinical response to biologics in psoriasis: A systematic review and meta‐analysis	32
Update on cutaneous lupus erythematosus pathogenesis, diagnosis and management	32
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis	31
Skin microbiome and its association with host cofactors in determining atopic dermatitis severity	31
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024	31
Application of integrated skincare in medical aesthetics: A literature review	31
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	31
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	31
Treatment of juvenile localized scleroderma with upadacitinib: A case series	31
Urinary incontinence and female genital lichen sclerosus	31
Patterns of regret for inadequate sun protection: A population‐based study [ HELIOS ]	30
	30
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	30
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use	30
	30
Delphi consensus on melasma management by international experts and pigmentary disorders society	30
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	30
Announcement	30
Pioneers in Dermatology and Venereology: an interview with Professor Jens‐Michael Schröder	29
	29
Issue Information	29
High‐dose intravenous immunoglobulin co‐treatment prolongs time‐to‐treatment escalation in autoimmune bullous diseases: A monocentric retrospective cohort study	29
Pioneers in Dermatology and Venereology: An interview with Professor Gil Yosipovitch	29
A cross‐sectional study of dermatologists' attitudes towards COVID‐19 vaccination in patients with immunobullous diseases	29
Evidence for differing roles of CD11c+CD163+ and CD11c−CD163+ cells in intracellular pigment storing in tattoos and stasis	28
Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study	28
Delay in the diagnosis and management of suspicious malignant skin lesions during the COVID‐19 pandemic in a reference centre in Mexico	28
Schnitzler syndrome associated with recurrent subacute thyroiditis and SARS‐CoV‐2 vaccine—A case review	28
Evidence for no genetic causal association between skin response to sun exposure and systemic lupus erythematosus: A Mendelian randomization study in Europeans and East Asians	28
Dermoscopic image colour correction based on gamma correction and multi‐scale image fusion	28
Heterologous versus homologous primary and booster COVID‐19 vaccination do not increase flare rate in patients with psoriasis and/or psoriatic arthritis: Insights from a real‐life, multicen	28
A case of advanced diffuse large B‐cell lymphoma diagnosed from widespread superficial mycosis of the skin	28
Deciphering differential response to NB‐UVB: The hair matters	28
Female genital mucosal lesions associated with COVID‐19 vaccination: A brief review of the literature	27
Response to ‘Dupilumab: No elevated maternal risks in propensity‐matched cohort’ by Preuß et al.	27
	27
A special thank you to our reviewers!	27
EADO classification of difficult‐to‐treat cutaneous squamous cell carcinoma in transplant recipients	27
Erectile dysfunction in patients with seborrhoeic dermatitis	27
Announcement	27
Effects of bariatric surgery on severe suppurative hidradenitis: Results of a nationwide administrative data study in France	27
Modest psoriasis risk from cardiometabolic progression: Genetics, patterns and limitations in a Biobank study	27
	27
Announcement	27
Beyond the blisters: An eight‐year invisible Odyssey through pemphigus vulgaris	26
Outcome and long‐term treatment protocol for topical tacrolimus in oral lichen planus	26
Real‐world experience of switching from tralokinumab to lebrikizumab in atopic dermatitis	26
	26
Beta‐blockers efficacy and safety in the treatment of PHACE syndrome: A systematic review	26
The Prurigo Control Test reflects the severity of itch and skin lesions in patients with chronic prurigo: Data from a real‐world study	26
Long‐term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial	25
Real‐world outcomes of biologics for hidradenitis suppurativa: A systematic review and meta‐analysis	25
Hair transplantation in folliculitis decalvans: Outcome description in a multicentre series of 11 patients	25
Timing, age and immune profiling refine strategy in lichenoid chronic GVHD – Authors' reply	25
Comment on “Psoriasis may increase the risk of lung cancer: A two‐sample Mendelian randomization study”	25
Molecular differentiation of psoriasis and eczema: Reference standards and benchmarking caveats	25
Beyond the surface: Integrating sex and gender in dermatologic therapy	25
Association of dermoscopic signs of regression in melanocytic lesions with immune checkpoint inhibitor response in metastatic melanoma patients	25
Burnout among French dermatologists: A national study	25
Scratching the surface: NK‐1 inhibitors for chronic itch—Promise or placebo?	25
Upadacitinib in dermatology: ‘Killing’ several diseases with one stone	24
Scabies treatment with benzyl benzoate in patients younger than 2 years: A single‐centre experience	24
A case of Anti‐MDA5‐Positive dermatomyositis after inactivated COVID‐19 vaccine	24
Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: Results of PREG‐CU, a UCARE study	24

Severity strata and minimally important differences of CompAQ and Skindex‐16 for patients with acne	24
Rifampicin and clindamycin for epidermal growth factor receptor inhibitor‐related acneiform rash	24
Linear and whorled hypermelanosis: A multicentre retrospective cohort of 33 patients	24
Impact of dermatologist shortage on melanoma diagnosis: A population‐based study	24
Comparison of the burden of pruritus and pain: Analysis of survey data from 4018 subjects	23
Optimizing management of immune checkpoint inhibitor‐induced pancreatic enzyme elevation: Risk‐based strategies	23
Thromboembolic risk with JAK inhibitors in atopic dermatitis: Context, caution and clinical relevance	23
Safety profile of risankizumab in the treatment of psoriasis patients with concomitant hepatitis B or C infection: A multicentric retrospective cohort study of 49 patients	23
Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment	23
Optical coherence tomography to differentiate squamous cell carcinoma from Bowen's disease and actinic keratosis	23
Upadacitinib improves symptoms of concomitant allergic rhinitis or allergic asthma in patients with severe atopic dermatitis: A 16‐week multicentre retrospective study	23
JAK inhibitor treatment for non‐infectious granulomatous skin diseases—A retrospective case study	23
Chronic pruritus in multiple sclerosis and clinical correlates	23
Response to Letter to the Editor—Assessing UWB ‐ RSOM for non‐invasive melanoma depth: Diagnostic	23
Association of hidradenitis suppurativa and malignancy: A systematic review and meta‐analysis	23
Announcement	23
High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid	22
Assessment of metabolic dysfunction‐associated steatotic liver disease in patients with hidradenitis suppurativa: A cross‐sectional study	22
Efficacy and safety of nemolizumab in paediatric atopic dermatitis: A 24‐week real‐world case series	22
What’s New in JEACP —Editor‐in‐Chief’s Insights	22
High‐frequency ultrasound accuracy in preoperative cutaneous melanoma assessment: A meta‐analysis	22
Cocaine‐induced plasma cell mucositis with osteocartilaginous destruction and atypical p‐ ANCA	22
Morphoea en coup de sabre with Adie's pupil: An exceptional association	22
Low‐dose oral minoxidil in female patients with lichen planopilaris: Real‐life experience	22
AI ‐assisted basal cell carcinoma diagnosis with LC ‐ OCT : A multi	22
Evaluation of risk in chronic cutaneous inflammatory conditions for malignant transformation	22
Ambassadors in Dermatology and Venereology: An interview with Professor Andreas Katsambas	21
Dermatologic adverse events associated with amivantamab: A multicentre study	21
Impact of COVID‐19 in patients with autoimmune bullous diseases: Report from an international registry	21
Global consensus on the management of melanin hyperpigmentation disorders	21
Announcement	21
Prevalence of hirsutism in Turkey: Data of the dermatoendocrinology study group	21
Editor’s Picks August 2026	21
A 5‐year retrospective cohort study of basal cell carcinomas on the head and neck: Anatomic location as a predictor of subclinical tumour extension	21
Pioneers in Dermatology and Venereology: An interview with Professor Johannes Ring	21
Infantile scabies misdiagnosed and treated as Langerhans cell histiocytosis: A case report	20
Study on hair root lipids of female androgenetic alopecia based on UPLC‐Q‐TOF/MS results	20
Phototype‐related Trichoscopic differences in lichen Planopilaris and frontal Fibrosing alopecia	20
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study	20
Declining invasive and rising in situ melanoma incidence trends in Iceland: A nationwide cohort study	20
Haematopoietic stem cell transplant in cutaneous T‐cell lymphomas: A multicentre propensity‐score matched study	20
A rare case of agminated juvenile Xanthogranuloma: Clinical and dermatoscopic evolution	20
Fears, concerns and expectations in dermatologic emergencies: A qualitative and descriptive study in a tertiary hospital	20
Efficacy and safety of biologics for hidradenitis suppurativa: A network meta‐analysis of phase III trials	20
Improved survival in married patients with metastatic Merkel cell carcinoma in the immunotherapy era	20
Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial	20
Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angio	20
The tumour triangle – A symbol‐based mnemonic for teaching important clinical characteristics of skin cancer	20
Reactive nonsexually related acute genital ulcers: A retrospective analysis of the Mayo Clinic experience	20
Wound healing and microbiome, an unexpected relationship	20
Concordance of in vivo reflectance confocal microscopy and horizontal‐sectioning histology in skin tumours	20
Risk score stratification of cutaneous melanoma patients based on whole slide images analysis by deep learning	19
Thirty years of promoting sun safety in France: The messages are heard but not followed!	19
Granular parakeratosis	19
Announcement	19
Reply to ‘Nail psoriasis: A rare mRNA COVID‐19 vaccine reaction’ by Lamberti A et al.	19
Number of melanoma deaths over time in relation to tumour thickness: Data from a Melanoma Unit Reference Center	19
Transcriptomic analysis of one patient with lupus skin lesions treated with anifrolumab	19
Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention	19
The SALT response index: Overcoming limitations of the SALT score for evaluating treatment respons	19
Premature skin ageing signs due to androgen deprivation therapy	19
Hidradenitis suppurativa: A prospective epidemiologic study in Albania	19
Tinea nigra with dermoscopic diagnosis: First autochthonous case in Italy?	19
Real‐life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study	19
The effect of abnormal secretion of DKK1 by fibroblasts on melanocytes function in vitiligo	19
Beyond surface: Rethinking prognostic boundaries in early mycosis fungoides	19
Probing into functional decline among bullous pemphigoid patients	19
A novel and effective therapy for Zoon balanitis: Topical crisaborole 2% ointment	19
Netherton syndrome and papillomatous lesions—Should we perform human papilloma virus vaccination?	19
Ultrasound features of hidradenitis suppurativa tunnels treated with bimekizumab	18
Merkel cell carcinoma from renal transplant recipients are mostly MCPyV‐negative and are frequently associated with squamous cell carcinomas or precursors	18
A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections	18
Cryosurgery versus curettage for intraepidermal carcinoma: A randomized controlled trial	18
A prospective, multicentre study to assess frailty in elderly patients with leg ulcers (GERASstudy)	18
A tale of two meta‐analyses: Similarity, consistency and avoiding overinterpretation in network meta‐analysis	18
Issue Information	18
Store‐and‐forward mobile application as an accessible method of study participant assessment	18
Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients	18
Dupilumab treatment for severe atopic dermatitis in children and SARS‐CoV‐2 infection: A combination of triggers for psoriasis	18
Defining ambiguity in molecular differentiation of psoriasis and eczema	18
Differing features of pemphigus in skin of colour versus white skin: A broad‐scale cohort study	18
Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide‐scale cohort study	18
Purtscher‐like retinopathy after hyaluronic filler injection for facial augmentation	18
Correction to ‘Classification of psychodermatological disorders: Proposal of a new international classification’	18
Merkel cell carcinoma after solid organ transplant	18
Skin reaction after SARS‐CoV‐2 vaccines Reply to ‘cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: A real‐life multicentre experience’	18
	18
Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023	17
Health‐related quality of life during different stages of decongestive therapy on patients with lymphoedema of the legs	17
AI‐assisted diagnosis of basal cell carcinoma via line‐field confocal OCT: Insights and limitations	17
Risk of adverse events of psoriasis treatment with biologic agents and new small molecules—BIOBADADERM Registry	17
Racial representation in dermatology clinical trials, a Canadian perspective	17
Stigmatizing attitudes towards facial psoriasis, atopic dermatitis, vitiligo and alopecia areata	17
Are interleukin 17 and interleukin 23 inhibitors associated with malignancies?—Insights from an international population‐based study	17
Trichophyton mentagrophytesITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon	17